Back to Agenda
[V1-S5] What Information and Communication Do Patients Want in Clinical Trials? How We Can Provide Them? (Part 1)
Session Chair(s)
Yasuhiro Fujiwara, MD, PhD
Chief Executive
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Yoshikata Furuya, MSc
Manager, General Affairs Division
Sankeien Hoshoukai Foundation, Japan
In order to engage patients as a partner in drug development and promote their involvement, it is important to understand patients’ needs in information and communication in clinical trials then provide them to patients. Disclosure of clinical trial information and provision of lay summaries of clinical trial results are beginning to be carried out in Japan. This session aims to understand what information and communication patients are seeking before, during and after clinical trials, and discuss how we should provide them to patients based on the regulations and case studies in Japan and global. In part 1 session, industry’s efforts, opinions from clinical trial sites and patients in Japan will be shared. In part 2 session, global status on patient communication will be stared and all speakers of part 1 and 2 sessions will have a panel discussion.
Speaker(s)
Clinical Trial Information for Patients - Current Status and Obstacles in Pharma Company -
Atsushi Kitamura, MS
Pfizer R&D Japan G.K., Japan
Director, Clinical Development Quality
Providing Information to Patients Who Participate in Clinical Trials: Efforts by Trial Sites
Nobuko Ushirozawa, RN
National Cancer Center, Japan
Chief, Research Admin. Div. Center for Research Admin and Support
Patients’ Needs in Communication and Information Sharing in Clinical Trials -1 - A cancer patient’s perspective-
Naomi Sakurai
CSR-Project, NPO, Japan
President
Patients’ Needs in Patient Communication and Information Sharing in Clinical Trials
Hiroki Takeda
Japan Chronic Diseases Self-Management Association, Japan
Executive Director
Have an account?